Lung Cancer Video Library - Molecular Testing At Initial Diagnosis Of Advanced Non-Small Cell Lung Cancer (NSCLC) Current Standards

Submitted by gracevideo on Mon, 10/30/2017 - 17:05

Stephen Liu, MD, GRACE Faculty
Dr. Stephen Liu

 

We are pleased to have Dr. Stephen Liu  bring us further 2017 updates for our 2017 Lung Cancer Video Library.  

Dr. Liu, a board-certified medical oncologist, specializes in lung cancer, cancers of the head and neck, and skin. Dr. Liu is a strong advocate of genomic testing to identify actionable mutations leading to the most effective, targeted therapies for personalized care. He is the recipient of many teaching and patient care awards. 

In this latest video, Dr. Liu discusses Current Standards - Molecular Testing At Initial Diagnosis Of Advanced Non-Small Cell Lung Cancer (NSCLC).

 

 

 

 We would like to thank the following companies for their support of this program

 

                

 

 

                        

 

 
 

 

 

  

Related Content: 
Arguing Against Molecular Testing for EGFR in NSCLC
What I really do: Molecular testing for NSCLC
Round Table Case-Based Discussion -- Drs. Laskin and Sandler on Molecular Testing in a Never-Smoker
Changing Clinical Practice: The Evidence that Convinced Me Many People with Advanced NSCLC Should Have Up Front Molecular Testing
ASCO vs. NCCN: Very Different Views on Molecular Testing in Advanced NSCLC
Dr. Sarah Goldberg: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?
Dr. Alan Sandler: Is There a Danger that the Latest Advances in Molecular Testing Are Only Available in Limited Specialty Settings?
Drs. Ross Camidge and Corey Langer: Who Do You Recommend Repeat Biopsy for if There Isn’t Enough Tissue for Molecular Testing?
What Molecular Markers Do You Prioritize for Molecular Testing in Advanced NSCLC, and Who do you Test?
Dr. Heather Wakelee: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Video Language: 
English

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation